SPTN Valuation
SpartanNash Co
$
0.000
- Overview
- Forecast
- Valuation
- Earnings
SPTN Relative Valuation
SPTN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SPTN is overvalued; if below, it's undervalued.
Historical Valuation
14.80
PE
1Y
3Y
5Y
Trailing
Forward
6.99
EV/EBITDA
SpartanNash Co. (SPTN) has a current EV/EBITDA of 6.99. The 5-year average EV/EBITDA is 6.85. The thresholds are as follows: Strongly Undervalued below 5.30, Undervalued between 5.30 and 6.07, Fairly Valued between 7.63 and 6.07, Overvalued between 7.63 and 8.40, and Strongly Overvalued above 8.40. The current Forward EV/EBITDA of 6.99 falls within the Historic Trend Line -Fairly Valued range.
14.63
EV/EBIT
SpartanNash Co. (SPTN) has a current EV/EBIT of 14.63. The 5-year average EV/EBIT is 13.18. The thresholds are as follows: Strongly Undervalued below 9.41, Undervalued between 9.41 and 11.30, Fairly Valued between 15.07 and 11.30, Overvalued between 15.07 and 16.96, and Strongly Overvalued above 16.96. The current Forward EV/EBIT of 14.63 falls within the Historic Trend Line -Fairly Valued range.
0.09
PS
SpartanNash Co. (SPTN) has a current PS of 0.09. The 5-year average PS is 0.09. The thresholds are as follows: Strongly Undervalued below 0.05, Undervalued between 0.05 and 0.07, Fairly Valued between 0.11 and 0.07, Overvalued between 0.11 and 0.12, and Strongly Overvalued above 0.12. The current Forward PS of 0.09 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
SpartanNash Co. (SPTN) has a current P/OCF of 0.00. The 5-year average P/OCF is 2.22. The thresholds are as follows: Strongly Undervalued below -2.57, Undervalued between -2.57 and -0.18, Fairly Valued between 4.61 and -0.18, Overvalued between 4.61 and 7.00, and Strongly Overvalued above 7.00. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
15.44
P/FCF
SpartanNash Co. (SPTN) has a current P/FCF of 15.44. The 5-year average P/FCF is 11.78. The thresholds are as follows: Strongly Undervalued below 4.68, Undervalued between 4.68 and 8.23, Fairly Valued between 15.33 and 8.23, Overvalued between 15.33 and 18.88, and Strongly Overvalued above 18.88. The current Forward P/FCF of 15.44 falls within the Overvalued range.
SpartanNash Co (SPTN) has a current Price-to-Book (P/B) ratio of NaN. Compared to its 3-year average P/B ratio of 1.04 , the current P/B ratio is approximately NaN% higher. Relative to its 5-year average P/B ratio of 1.08, the current P/B ratio is about NaN% higher. SpartanNash Co (SPTN) has a Forward Free Cash Flow (FCF) yield of approximately NaN%. Compared to its 3-year average FCF yield of 2.86%, the current FCF yield is approximately NaN% lower. Relative to its 5-year average FCF yield of 8.52% , the current FCF yield is about NaN% lower.
1.23
P/B
Median3y
1.04
Median5y
1.08
7.67
FCF Yield
Median3y
2.86
Median5y
8.52
Competitors Valuation Multiple
The average P/S ratio for SPTN's competitors is 0.05, providing a benchmark for relative valuation. SpartanNash Co Corp (SPTN) exhibits a P/S ratio of 0.09, which is 100.00% above the industry average. Given its robust revenue growth of 1.81%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SPTN increased by 24.05% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -33.67 to -57.35.
The secondary factor is the Revenue Growth, contributed 1.81%to the performance.
Overall, the performance of SPTN in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
SLP
Simulations Plus Inc
15.030
USD
-1.44%
CLMB
Climb Global Solutions Inc
136.065
USD
+2.95%
CCRN
Cross Country Healthcare Inc
13.370
USD
-1.26%
ABUS
Arbutus Biopharma Corp
4.430
USD
+4.24%
CAN
Canaan Inc
0.736
USD
-5.52%
LEGH
Legacy Housing Corp
27.310
USD
+0.33%
RGR
Sturm Ruger & Company Inc
40.360
USD
+1.59%
TECX
Tectonic Therapeutic Inc
15.780
USD
+5.34%
FAQ
Is SpartanNash Co (SPTN) currently overvalued or undervalued?
SpartanNash Co (SPTN) is now in the Fair zone, suggesting that its current forward PE ratio of NaN is considered Fairly compared with the five-year average of 11.43. The fair price of SpartanNash Co (SPTN) is between to according to relative valuation methord.
What is SpartanNash Co (SPTN) fair value?
How does SPTN's valuation metrics compare to the industry average?
What is the current P/B ratio for SpartanNash Co (SPTN) as of Sep 23 2025?
What is the current FCF Yield for SpartanNash Co (SPTN) as of Sep 23 2025?
What is the current Forward P/E ratio for SpartanNash Co (SPTN) as of Sep 23 2025?